SAGE Therapeutics Company
SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
Technology:
P4 Medicine
Industry:
Neuropharmacology
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
7-2
Employees Number:
501-1000
Funding Status:
N/A
Investors Number:
5
Total Funding:
$438M
Estimated Revenue:
$50M to $100M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership